Mauriello

Adamis Pharmaceuticals Stock Analysis ADMP

看多
NASDAQ:ADMP   None
The Idea is to go long as per Technical and Fundamental Analysis. Wait the possible end of the price set back before going long.
Shares of Adamis Pharmaceuticals Corporation ADMP surged 77.6% after it submitted an investigational new drug (IND) application to the FDA to begin a clinical study onTempol for thetreatment and prevention ofCOVID-19.
NASDAQ:ADMP

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。